within Pharmacolibrary.Drugs.ATC.N;

model N05CA15
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 1,
    Cl             = 3.6666666666666665,
    adminDuration  = 600,
    adminMass      = 0.1,
    adminCount     = 1,
    Vd             = 0.0025,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.0,
    Tlag           = 0
  );

  annotation(Documentation(
    info ="<html><body><p>Methohexital is a short-acting barbiturate anesthetic agent used primarily for induction of anesthesia and for short surgical procedures. It is administered intravenously and has been used for induction in both adults and children. The drug is no longer as widely used due to the availability of newer agents but remains approved and available in some countries for specific applications such as rapid anesthesia induction and electroconvulsive therapy.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters reported in healthy adult patients after a single intravenous bolus administration.</p><h4>References</h4><ol><li><p>Bally, B, et al., &amp; Stieglitz, P (1992). [Pharmacokinetics of methohexital given by constant rate intravenous infusion]. <i>Annales francaises d&#x27;anesthesie et de reanimation</i> 11(2) 136–140. DOI:<a href=&quot;https://doi.org/10.1016/s0750-7658(05)80003-6&quot;>10.1016/s0750-7658(05)80003-6</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/1503284/&quot;>https://pubmed.ncbi.nlm.nih.gov/1503284</a></p></li><li><p>Čižmáriková, R, et al., &amp; Markulia, M (2023). General intravenous anesthetics - pharmacodynamics, pharmacokinetics and chiral properties. <i>Ceska a Slovenska farmacie : casopis Ceske farmaceuticke spolecnosti a Slovenske farmaceuticke spolecnosti</i> 72(4) 155–164. PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/37805261/&quot;>https://pubmed.ncbi.nlm.nih.gov/37805261</a></p></li><li><p>Ghoneim, MM, &amp; Korttila, K (1977). Pharmacokinetics of intravenous anaesthetics: implications for clinical use. <i>Clinical pharmacokinetics</i> 2(5) 344–372. DOI:<a href=&quot;https://doi.org/10.2165/00003088-197702050-00003&quot;>10.2165/00003088-197702050-00003</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/21053/&quot;>https://pubmed.ncbi.nlm.nih.gov/21053</a></p></li></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>"
  ));
end N05CA15;
